IR-Med, Inc. financial data

Symbol
IRME on OTC
Industry
Electromedical & Electrotherapeutic Apparatus
Location
C/O Aboudi Legal Group Pllc, 745 5 Th Ave, Suite 500, New York, NY
State of incorporation
NV
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 312 %
Debt-to-equity 129 % +406%
Return On Equity -749 % -243%
Return On Assets -328 % -88.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 70.7M shares +1.3%
Common Stock, Shares, Outstanding 69.9M shares +1.63%
Entity Public Float 40.2M USD -47.2%
Common Stock, Value, Issued 70K USD +1.45%
Weighted Average Number of Shares Outstanding, Basic 70.3M shares +1.81%
Weighted Average Number of Shares Outstanding, Diluted 70.3M shares +1.81%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.25M USD -40.4%
General and Administrative Expense 1.54M USD -35.2%
Operating Income (Loss) -3.48M USD +35.5%
Nonoperating Income (Expense) 2K USD +11.1%
Net Income (Loss) Attributable to Parent -3.47M USD +35.7%
Earnings Per Share, Basic -0.05 USD/shares +44.4%
Earnings Per Share, Diluted -0.05 USD/shares +50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 753K USD -67.8%
Accounts Receivable, after Allowance for Credit Loss, Current 36K USD -63.6%
Assets, Current 789K USD -67.6%
Property, Plant and Equipment, Net 42K USD -27.6%
Operating Lease, Right-of-Use Asset 45K USD -61.9%
Assets 887K USD -66.2%
Accounts Payable, Current 64K USD -22.9%
Employee-related Liabilities, Current 98K USD +5.38%
Accrued Liabilities, Current 160K USD +21.2%
Liabilities, Current 473K USD -28.6%
Long-term Debt and Lease Obligation 13K USD -83.3%
Operating Lease, Liability, Noncurrent 2K USD
Liabilities 524K USD -14.7%
Retained Earnings (Accumulated Deficit) -15.9M USD -28%
Stockholders' Equity Attributable to Parent 363K USD -81.9%
Liabilities and Equity 887K USD -66.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -358K USD +60.2%
Net Cash Provided by (Used in) Investing Activities -20K USD -186%
Common Stock, Shares Authorized 600M shares +140%
Common Stock, Shares, Issued 70.7M shares +1.25%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -359K USD +60.1%
Deferred Tax Assets, Valuation Allowance 2.1M USD +44.3%
Deferred Tax Assets, Gross 2.12M USD +42.2%
Operating Lease, Liability 39K USD -65.8%
Depreciation 9K USD +125%
Payments to Acquire Property, Plant, and Equipment 11K USD +57.1%
Lessee, Operating Lease, Liability, to be Paid 50K USD -58.3%
Property, Plant and Equipment, Gross 93K USD +2.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11K USD +83.3%
Deferred Tax Assets, Operating Loss Carryforwards 1.68M USD +50.1%
Additional Paid in Capital 16.2M USD +12.8%
Share-based Payment Arrangement, Expense 53K USD